Congress planning today: Pain points and opportunities

Between December 2023 and February 2024, we conducted a two-phase multi-methodology research study, collecting feedback from global pharmaceutical company employees whose job roles involve the planning and delivery of congress.

In this report, we uncover the challenges faced by congress planners working in pharma, what is required to mitigate these challenges, and ultimately, how you can improve the execution of future congress events. We explore key research and findings, such as:

• ‘Congress is still a high-value activity for pharma’
• ‘Value is being lost in the complexities of delivery’
• ‘Smarter ROI measurements reveal known unknowns’
• ‘Overcoming complexities in congress execution’